Literature DB >> 17363220

Double dissociation of N1 and P3 abnormalities in deficit and nondeficit schizophrenia.

Armida Mucci1, Silvana Galderisi, Brian Kirkpatrick, Paola Bucci, Umberto Volpe, Eleonora Merlotti, Fausto Centanaro, Francesco Catapano, Mario Maj.   

Abstract

It has been proposed that the presence of enduring, idiopathic negative symptoms define a group of patients with a disease (deficit schizophrenia, DS) that is separate from other forms of schizophrenia (nondeficit schizophrenia, NDS). Although several findings support this hypothesis, the possibility that DS represents the severe end of a single schizophrenia continuum cannot be excluded yet. We tested the hypothesis that DS and NDS differ relative to event-related potentials (ERPs). Amplitude, scalp topography and cortical sources of the ERP components were assessed in clinically stable DS and NDS outpatients and in matched healthy subjects (HCS). Twenty subjects per group were recruited. Among the subjects who completed the target detection task, there were no group difference in accuracy. For N1, only patients with DS, as compared with HCS, showed an amplitude reduction over the scalp central leads and a reduced current source density in cingulate and parahippocampal gyrus. For P3, only patients with NDS, as compared with HCS, showed a lateralized amplitude reduction over the left posterior regions and reduced current source density in left temporal and bilateral frontal, cingulate and parietal areas. The DS and NDS groups differed significantly from each other with regard to N1 amplitude and topography, as well as P3 amplitude and cortical sources. The N1 was affected in DS but not in NDS patients, whereas P3 was affected in NDS only. This double dissociation is consistent with the hypothesis that DS represents a separate disease entity within schizophrenia.

Entities:  

Mesh:

Year:  2007        PMID: 17363220     DOI: 10.1016/j.schres.2007.01.026

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  15 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

2.  Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.

Authors:  Clemente Garcia-Rizo; Emilio Fernandez-Egea; Cristina Oliveira; Azucena Justicia; Miguel Bernardo; Brian Kirkpatrick
Journal:  Psychiatry Res       Date:  2012-03-08       Impact factor: 3.222

3.  Differences in glucose tolerance between deficit and nondeficit schizophrenia.

Authors:  Brian Kirkpatrick; Emilio Fernandez-Egea; Clemente Garcia-Rizo; Miguel Bernardo
Journal:  Schizophr Res       Date:  2008-11-28       Impact factor: 4.939

4.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

5.  Progress in the study of negative symptoms.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

6.  TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia.

Authors:  David R Goldsmith; Ebrahim Haroon; Andrew H Miller; Gregory P Strauss; Peter F Buckley; Brian J Miller
Journal:  Schizophr Res       Date:  2018-02-28       Impact factor: 4.939

7.  Dysfunctional attitudes and expectancies in deficit syndrome schizophrenia.

Authors:  Aaron T Beck; Paul M Grant; Gloria A Huh; Dimitri Perivoliotis; Nadine A Chang
Journal:  Schizophr Bull       Date:  2011-05-27       Impact factor: 9.306

8.  Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia.

Authors:  Silvana Galderisi; Mario Quarantelli; Umberto Volpe; Armida Mucci; Giovanni Battista Cassano; Giordano Invernizzi; Alessandro Rossi; Antonio Vita; Stefano Pini; Paolo Cassano; Enrico Daneluzzo; Luca De Peri; Paolo Stratta; Arturo Brunetti; Mario Maj
Journal:  Schizophr Bull       Date:  2007-08-28       Impact factor: 9.306

9.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

10.  Deficit schizophrenia: Concept and validity.

Authors:  Sandeep Grover; Parmanand Kulhara
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.